SVRA · Savara Inc
United States · RS rating 42 · As of 2026-11-03
| Price | 4.75 USD |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 54 / 39 / 64 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 9 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -6.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +31.6% |
| Market cap (USD) | $1.0B |